MILabs offers arguably the best preclinical imaging platform in the market today. Its individual modalities, whether PET, SPECT, Optical Imaging or CT, offer performance and functionality beyond the capabilities of any other small animal imaging system.
Moreover, the platform is fully scalable, including any combination as illustrated above, thus fully exploiting the synergies between modalities by the unique fusion of both hardware and software. Now it is even possible to perform simultaneous acquisitions of multiple co-injected PET and PET/SPECT tracers and Optical Tomography using segmented CT information.
Now, more than ever, the whole system is greater than the sum of its parts.